Getting patients well, keeping them well, and focusing on a cure
Do I Have CGD?
After Being Diagnosed
General Information about CGD
Support for Parents/Patients
Wish Foundations
Kids/Teens/Young Adults
Doctor Visits & Hospitalizations
Specific Infecting Organisms
Drug Therapies
Specific Disease Help
Your Time in the Hospital
Financial Help
Sibling Support
Updates on CGD Patients (2011)
Updates on CGD Patients (2013)
Professional PID Links
Awarded Grants
Clinical Trials
Donate Now!
Contact & Nonprofit Info
Welcome to the website for the Chronic Granulomatous Disease Association (CGDA)! The information on this website is written for those concerned with Chronic Granulomatous Disease. It is not meant to replace seeking medical advice. Always consult your doctor.
We are an IRC 501C(3) nonprofit corporation dedicated to helping those with CGD and advancing research toward a cure. All donations are tax deductible. 100% of your donation goes towards CGD research. We receive no salaries or pay any rent. Any additional expenses are paid for by an outside donor. Your donations are greatly appreciated!
Coming Up!
2015 The Chronic Granulomatous Disease Association (CGDA) will be launching a redesigned new website with more added material. We are an international organization so wherever you live if you have CGD or know someone that does, please offer your suggestions. Thanks to our dear CGD families!
Thanks to your donations the CGDA will be donating funds for patient travel and housing for this very important study, A Phase I/II, Non-Randomized, Multicenter, Open-Label Study of G1XCGD (Lentiviral Vector Transduced CD34+ Cells) in Patients with X-Linked Chronic Granulomatous Disease. Please donate so the CGDA can give more to finding a cure for CGD.
The CGD Association hopes to issue another grant of $25,000 for CGD research. We are especially interested in gene therapy or zinc finger nuclease-mediated gene targeting. Both may lead to a cure for CGD and the research may help other diseases as well.
Yes! - 100% of your donation goes towards CGD research.